A. Lamy
Institut de Recherche en Sémiochimie et Ethologie Appliquée(FR)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics, Cancer Treatment and Pharmacology
Most-Cited Works
- → Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy(2007)733 cited
- → TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy(2009)84 cited
- → Molecular Profiling of Bladder Tumors Based on the Detection of FGFR3 and TP53 Mutations(2006)72 cited
- → Association of FcγRIIa and FcγRIIa polymorphisms with clinical outcome in metastatic colorectal cancer patients (mCRC) treated with cetuximab and irinotecan(2008)21 cited
- → Re: Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas(2001)9 cited
- → KRAS mutation is highly predictive of cetuximab resistance in metastatic colorectal cancer(2007)9 cited
- → TP53 mutations in irinotecan-refractory KRAS wt-BRAF wt metastatic colorectal cancer patients treated with cetuximab-based chemotherapy.(2011)6 cited
- → Major response to temozolomide as first-line treatment for newly-diagnosed DDR2-mutated glioblastoma: A case report(2020)5 cited
- → Multiscale In Silico Study of the Mechanism of Activation of the RtcB Ligase by the PTP1B Phosphatase(2024)5 cited
- → First national external quality assessment for the interpretation of somatic variants: Assessment of 25 variants in colorectal, lung, ovarian cancers and melanoma in France(2019)1 cited